|1.||Delivoria-Papadopoulos, Maria: 6 articles (12/2006 - 11/2004)|
|2.||Enkhbaatar, Perenlei: 3 articles (12/2011 - 08/2003)|
|3.||Tumas, V: 3 articles (11/2010 - 03/2005)|
|4.||Padovan-Neto, F E: 3 articles (11/2010 - 03/2005)|
|5.||Del Bel, E A: 3 articles (11/2010 - 03/2005)|
|6.||Mishra, Om Prakash: 3 articles (12/2006 - 11/2004)|
|7.||Mishra, Om P: 3 articles (10/2006 - 06/2006)|
|8.||Czuczwar, S J: 3 articles (09/2006 - 01/2000)|
|9.||Tao, Y-X: 3 articles (01/2004 - 01/2002)|
|10.||Johns, R A: 3 articles (01/2004 - 01/2002)|
05/11/2001 - "nNOS upregulation 1 and 2 days after seizures and protection against HBO(2) seizures by nNOS-specific inhibitor 7-nitroindazole (7-NI) suggest possible involvement of NO in the mechanism of increased sensitivity to HBO(2) in reexposures."
10/01/2003 - "There are no reports on the effect of 7-nitroindazole (7-NI) on chemically-induced convulsions. "
08/01/2003 - "The specific neuronal nitric oxide synthase (NOS) inhibitor, 7-nitroindazole (7-NI), significantly reduced the increases in seizure-induced protein NT and protein carbonyl and at the same time very effectively (p<0.05) delayed onset of HBO2 seizures. "
01/01/2012 - "Therefore, the aim of this study was to determine the effects of 7-nitroindazole, a selective nNOS inhibitor, on behavioral manifestations of homocysteine - induced seizures in adult rats. "
03/01/2007 - "In this study, we investigated whether the inhibition of NOS by 7-nitroindazole (7-NI, 3-60mg/kg, i.p.) altered the convulsions, protein oxidative damage, NO(x) (NO(2) plus NO(3)) production and Na(+),K(+)-ATPase activity inhibition induced by MMA. "
01/01/2004 - "The present study tested the hypothesis that hypoxia results in altered expression and activity of MKP-1 and MKP-3 in neuronal nuclei and the administration of 7-nitro-indazole (7-NINA; 1 mg/kg, 60 min prior to hypoxia), a selective nNOS inhibitor, will prevent the hypoxia-induced alteration in the expression and activity of MKP-1 and MKP-3. "
09/01/2014 - "In primary cultures of RGCs subjected to hypoxia, the upregulation of nNOS and NO was significantly suppressed when treated with 7-nitroindazole (7-NINA), an nNOS inhibitor or BAY, an NF-κB inhibitor. "
01/01/2008 - "Administration of the selective nNOS inhibitor 7-nitroindazole 20 min before hypoxia prevented complex I inhibition and most ultrastructural damage. "
09/01/2000 - "Rats were submitted to hypoxia, 7-nitroindazole (7-NI; a selective nNOS inhibitor) injection, or both treatments together. "
08/01/2000 - "Effect of 7-nitroindazole upon cochlear dysfunction induced by transient local anoxia."
|3.||Brain Ischemia (Cerebral Ischemia)
07/01/1999 - "In the present study NOS activities were evaluated in cerebellum and cerebral cortex of ischemic and post-ischemic reperfused rats using an experimental model of partial cerebral ischemia; moreover, the effects of L-N(G)Nitroarginine (NA, nonselective NOS inhibitor) or 7-Nitroindazole (7-NI, selective neuronal NOS inhibitor) administration were assayed on percentage survival of ischemic rats. "
04/01/2007 - "Inhibition of nitric oxide synthase with 7-nitroindazole does not modify early metabolic recovery following focal cerebral ischemia in rats."
06/18/1999 - "7-Nitroindazole attenuates nitrotyrosine formation in the early phase of cerebral ischemia-reperfusion in mice."
01/01/2003 - "The purpose of this study was to test the hypothesis that the efficacy of 7-nitroindazole (7-NI), a selective neuronal nitric oxide (NO) synthase (NOS) inhibitor, is pH dependent in vivo during focal cerebral ischemia. "
01/20/2012 - "Our results show that the administration of 7-nitroindazole, an inhibitor of neuronal NO synthase (nNOS), or nNOS antisense oligodeoxynucleotides diminished the S-nitrosylation of MLK3 and inhibited its activation induced by cerebral ischemia/reperfusion. "
01/01/2012 - "7-Nitroindazole and its rapidly emerging role in opioid pain management and withdrawal."
06/08/2001 - "Electrical stimulation of the secondary somatosensory cortex (S-II), which is clinically effective in some chronic pain patients, produces a weak antinociception by itself and also strongly facilitates the antinociceptive effect of the neuronal NO synthase inhibitor 7-nitro-indazole in laboratory animals (rats). "
01/01/2011 - "L-NAME, a non-selective NOS inhibitor, and 7-nitroindazole, a neuronal NOS (nNOS) inhibitor, significantly suppressed the oxaliplatin-induced pain behavior. "
01/13/2006 - "administration of NOS inhibitors aminoguanidine, L-N(G)-nitroarginine methyl ester and 7-nitroindazole caused alleviation of pain. "
12/15/2005 - "Furthermore, intrathecal injection of either L-NAME or 7-nitroindazole, a selective nNOS inhibitor, markedly attenuated mechanical pain hypersensitivity at both 2 and 24h after CFA injection. "
12/01/2011 - "7-Nitroindazole injection into the bronchial artery reduced the degree of lung edema formation and improved pulmonary gas exchange. "
03/01/1995 - "The possible modulatory role of nitric oxide (NO) in neurogenic edema formation in rat paw skin, induced by electrical stimulation of the saphenous nerve, was investigated by using two NO synthase inhibitors, NG-nitro-L-arginine methyl ester (L-NAME) and 7-nitroindazole (7-NI). "
|1.||Nitric Oxide Synthase (NO Synthase)
|2.||NG-Nitroarginine Methyl Ester (L-NAME)
|3.||Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)
|4.||Nitric Oxide (Nitrogen Monoxide)
|6.||Adenosine Triphosphatases (ATPase)
|10.||Nitroarginine (NG Nitro L Arginine)